Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Novel Filtration System Removes Proteins and Phospholipids from Analytical Samples

By BiotechDaily International staff writers
Posted on 03 Feb 2014
Image: The ISOLUTE PLD+ protein and phospholipid removal plate (Photo courtesy of Biotage).
Image: The ISOLUTE PLD+ protein and phospholipid removal plate (Photo courtesy of Biotage).
Biotechnology and other life science researchers now have available a novel filter system that removes both proteins and phospholipids, which leaves samples ready for LC-MS/MS (liquid chromatography-mass spectroscopy) analysis.

The Biotage (Uppsala, Sweden) ISOLUTE PLD+ plate combines protein and phospholipid removal from blood-based matrix samples and provides simple and effective cleanup for LC-MS/MS analysis. According to the manufacturer, ISOLUTE PLD+ plates remove more than 99% of plasma proteins and phospholipids, the main causes of ion suppression, leading to cleaner extracts and increased sensitivity, signal-to-noise, for a broad range of analytes.

ISOLUTE PLD+ plates are available in standard 96-well format and can handle sample volumes of 100 to 200 microliters. Operation of the ISOLUTE PLD+ plate includes a filtration step that can be accomplished with a 96-well compatible positive pressure manifold (such as the Biotage Pressure+ 96), a vacuum manifold (for example the Biotage VacMaster 96) and most automated liquid handling systems.

“Requiring next to no method development, ISOLUTE PLD+ can be integrated quickly and easily into routine workflow, increasing productivity and reducing instrument downtime,” said Paul Roberts, analytical product manager at Biotage.

Related Links:

Biotage



Channels

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.